{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:23:25Z","timestamp":1791210205439,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00415-020-09932-y","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T02:18:18Z","timestamp":1591669098000},"page":"3021-3037","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Platelet function\/reactivity testing and prediction of risk of recurrent vascular events and outcomes after TIA or ischaemic stroke: systematic review and meta-analysis"],"prefix":"10.1007","volume":"267","author":[{"given":"Soon Tjin","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Thijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J. X.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Fernandez-Cadenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Montaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika","family":"Offiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Marquardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Bath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Yin","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Norrving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dermot","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calin I.","family":"Prodan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Werring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zgaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0493-4516","authenticated-orcid":false,"given":"Dominick J. H.","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,9]]},"reference":[{"issue":"3","key":"9932_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","volume":"379","author":"SC Johnston","year":"2018","unstructured":"Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, Kim AS, Lindblad AS, Palesch YY, Clinical Research Collaboration NETTN (2018) Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med 379(3):215\u2013225. https:\/\/doi.org\/10.1056\/NEJMoa1800410","journal-title":"N Engl J Med"},{"key":"9932_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.2531","author":"Y Pan","year":"2019","unstructured":"Pan Y, Elm JJ, Li H, Easton JD, Wang Y, Farrant M, Meng X, Kim AS, Zhao X, Meurer WJ, Liu L, Dietrich D, Wang Y, Johnston SC (2019) Outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack: a pooled analysis of clopidogrel in high-risk patients with acute non-disabling cerebrovascular events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2019.2531","journal-title":"JAMA Neurol"},{"issue":"4","key":"9932_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1474-4422(06)70408-2","volume":"5","author":"PM Rothwell","year":"2006","unstructured":"Rothwell PM, Buchan A, Johnston SC (2006) Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. Lancet Neurol 5(4):323\u2013331. https:\/\/doi.org\/10.1016\/S1474-4422(06)70408-2","journal-title":"Lancet Neurol"},{"issue":"9","key":"9932_CR4","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMp1500523","volume":"372","author":"FS Collins","year":"2015","unstructured":"Collins FS, Varmus H (2015) A new initiative on precision medicine. N Engl J Med 372(9):793\u2013795. https:\/\/doi.org\/10.1056\/NEJMp1500523","journal-title":"N Engl J Med"},{"issue":"7637","key":"9932_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/bmj.39430.529549.BE","volume":"336","author":"G Krasopoulos","year":"2008","unstructured":"Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR (2008) Aspirin \u201cresistance\u201d and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ 336(7637):195\u2013198. https:\/\/doi.org\/10.1136\/bmj.39430.529549.BE","journal-title":"BMJ"},{"issue":"11","key":"9932_CR6","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.jocn.2008.01.006","volume":"15","author":"D Bennett","year":"2008","unstructured":"Bennett D, Yan B, Macgregor L, Eccleston D, Davis SM (2008) A pilot study of resistance to aspirin in stroke patients. J Clin Neurosci 15(11):1204\u20131209. https:\/\/doi.org\/10.1016\/j.jocn.2008.01.006","journal-title":"J Clin Neurosci"},{"issue":"5","key":"9932_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0049-3848(93)90164-J","volume":"71","author":"KH Grotemeyer","year":"1993","unstructured":"Grotemeyer KH, Scharafinski HW, Husstedt IW (1993) Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients. Thromb Res 71(5):397\u2013403","journal-title":"Thromb Res"},{"issue":"14","key":"9932_CR8","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1161\/01.CIR.0000013777.21160.07","volume":"105","author":"JW Eikelboom","year":"2002","unstructured":"Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S (2002) Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 105(14):1650\u20131655","journal-title":"Circulation"},{"issue":"6","key":"9932_CR9","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","volume":"41","author":"PA Gum","year":"2003","unstructured":"Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ (2003) A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 41(6):961\u2013965","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"9932_CR10","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.jacc.2004.08.070","volume":"46","author":"PJ Mason","year":"2005","unstructured":"Mason PJ, Jacobs AK, Freedman JE (2005) Aspirin resistance and atherothrombotic disease. J Am Coll Cardiol 46(6):986\u2013993. https:\/\/doi.org\/10.1016\/j.jacc.2004.08.070","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"9932_CR11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ahj.2010.06.004","volume":"160","author":"D Aradi","year":"2010","unstructured":"Aradi D, Komocsi A, Vorobcsuk A, Rideg O, Tokes-Fuzesi M, Magyarlaki T, Horvath IG, Serebruany VL (2010) Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis. Am Heart J 160(3):543\u2013551. https:\/\/doi.org\/10.1016\/j.ahj.2010.06.004","journal-title":"Am Heart J"},{"issue":"5","key":"9932_CR12","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1111\/j.1538-7836.2010.03809.x","volume":"8","author":"C Combescure","year":"2010","unstructured":"Combescure C, Fontana P, Mallouk N, Berdague P, Labruyere C, Barazer I, Gris JC, Laporte S, Fabbro-Peray P, Reny JL, Clopidogrel Vascular, Vascular IEM-aSG (2010) Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis. J Thromb Haemost 8(5):923\u2013933. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03809.x","journal-title":"J Thromb Haemost"},{"issue":"4","key":"9932_CR13","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1160\/TH09-06-0418","volume":"103","author":"F Sofi","year":"2010","unstructured":"Sofi F, Marcucci R, Gori AM, Giusti B, Abbate R, Gensini GF (2010) Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An updated meta-analysis. Thromb Haemost 103(4):841\u2013848. https:\/\/doi.org\/10.1160\/TH09-06-0418","journal-title":"Thromb Haemost"},{"issue":"3","key":"9932_CR14","doi-asserted-by":"publisher","first-page":"e000703","DOI":"10.1161\/JAHA.112.000703","volume":"1","author":"AA Pettersen","year":"2012","unstructured":"Pettersen AA, Seljeflot I, Abdelnoor M, Arnesen H (2012) High On-aspirin platelet reactivity and clinical outcome in patients with stable coronary artery disease: results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial). J Am Heart Assoc 1(3):e000703. https:\/\/doi.org\/10.1161\/JAHA.112.000703","journal-title":"J Am Heart Assoc"},{"issue":"25","key":"9932_CR15","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1161\/CIRCULATIONAHA.111.085464","volume":"125","author":"JL Reny","year":"2012","unstructured":"Reny JL, Berdague P, Poncet A, Barazer I, Nolli S, Fabbro-Peray P, Schved JF, Bounameaux H, Mach F, de Moerloose P, Fontana P, Antiplatelet Drug R, Ischemic Events Study G (2012) Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study. Circulation 125(25):3201\u20133210. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.085464","journal-title":"Circulation"},{"issue":"19","key":"9932_CR16","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.jacc.2011.06.059","volume":"58","author":"SS Brar","year":"2011","unstructured":"Brar SS, ten Berg J, Marcucci R, Price MJ, Valgimigli M, Kim HS, Patti G, Breet NJ, DiSciascio G, Cuisset T, Dangas G (2011) Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data. J Am Coll Cardiol 58(19):1945\u20131954. https:\/\/doi.org\/10.1016\/j.jacc.2011.06.059","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"9932_CR17","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","volume":"367","author":"JP Collet","year":"2012","unstructured":"Collet JP, Cuisset T, Range G, Cayla G, Elhadad S, Pouillot C, Henry P, Motreff P, Carrie D, Boueri Z, Belle L, Van Belle E, Rousseau H, Aubry P, Monsegu J, Sabouret P, O\u2019Connor SA, Abtan J, Kerneis M, Saint-Etienne C, Barthelemy O, Beygui F, Silvain J, Vicaut E, Montalescot G, Investigators A (2012) Bedside monitoring to adjust antiplatelet therapy for coronary stenting. N Engl J Med 367(22):2100\u20132109. https:\/\/doi.org\/10.1056\/NEJMoa1209979","journal-title":"N Engl J Med"},{"issue":"11","key":"9932_CR18","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1001\/jama.2011.290","volume":"305","author":"MJ Price","year":"2011","unstructured":"Price MJ, Berger PB, Teirstein PS, Tanguay JF, Angiolillo DJ, Spriggs D, Puri S, Robbins M, Garratt KN, Bertrand OF, Stillabower ME, Aragon JR, Kandzari DE, Stinis CT, Lee MS, Manoukian SV, Cannon CP, Schork NJ, Topol EJ, Investigators G (2011) Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA 305(11):1097\u20131105. https:\/\/doi.org\/10.1001\/jama.2011.290","journal-title":"JAMA"},{"issue":"5","key":"9932_CR19","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/j.ijcard.2012.05.100","volume":"167","author":"D Aradi","year":"2013","unstructured":"Aradi D, Komocsi A, Price MJ, Cuisset T, Ari H, Hazarbasanov D, Trenk D, Sibbing D, Valgimigli M, Bonello L, Tailored Antiplatelet Treatment Study C (2013) Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysis. Int J Cardiol 167(5):2140\u20132148. https:\/\/doi.org\/10.1016\/j.ijcard.2012.05.100","journal-title":"Int J Cardiol"},{"issue":"24","key":"9932_CR20","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1093\/eurheartj\/ehz202","volume":"40","author":"D Aradi","year":"2019","unstructured":"Aradi D, Gross L, Trenk D, Geisler T, Merkely B, Kiss RG, Komocsi A, Dezsi CA, Ruzsa Z, Ungi I, Rizas KD, May AE, Mugge A, Zeiher AM, Holdt L, Huber K, Neumann FJ, Koltowski L, Huczek Z, Hadamitzky M, Massberg S, Sibbing D (2019) Platelet reactivity and clinical outcomes in acute coronary syndrome patients treated with prasugrel and clopidogrel: a pre-specified exploratory analysis from the TROPICAL-ACS trial. Eur Heart J 40(24):1942\u20131951. https:\/\/doi.org\/10.1093\/eurheartj\/ehz202","journal-title":"Eur Heart J"},{"issue":"1","key":"9932_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24(1):35\u201341","journal-title":"Stroke"},{"issue":"5","key":"9932_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3109\/09537104.2015.1049139","volume":"26","author":"ST Lim","year":"2015","unstructured":"Lim ST, Coughlan CA, Murphy SJ, Fernandez-Cadenas I, Montaner J, Thijs V, Marquardt L, McCabe DJ (2015) Platelet function testing in transient ischaemic attack and ischaemic stroke: a comprehensive systematic review of the literature. Platelets 26(5):402\u2013412. https:\/\/doi.org\/10.3109\/09537104.2015.1049139","journal-title":"Platelets"},{"key":"9932_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jns.2017.03.010","volume":"376","author":"A Fiolaki","year":"2017","unstructured":"Fiolaki A, Katsanos AH, Kyritsis AP, Papadaki S, Kosmidou M, Moschonas IC, Tselepis AD, Giannopoulos S (2017) High on treatment platelet reactivity to aspirin and clopidogrel in ischemic stroke: a systematic review and meta-analysis. J Neurol Sci 376:112\u2013116. https:\/\/doi.org\/10.1016\/j.jns.2017.03.010","journal-title":"J Neurol Sci"},{"key":"9932_CR24","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DGP, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535. https:\/\/doi.org\/10.1136\/bmj.b2535","journal-title":"BMJ"},{"issue":"1","key":"9932_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.116.025198","volume":"135","author":"T Simon","year":"2017","unstructured":"Simon T, Danchin N (2017) Clinical impact of pharmacogenomics of clopidogrel in stroke. Circulation 135(1):34\u201337. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.025198","journal-title":"Circulation"},{"issue":"1","key":"9932_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/jama.2016.8662","volume":"316","author":"Y Wang","year":"2016","unstructured":"Wang Y, Zhao X, Lin J, Li H, Johnston SC, Lin Y, Pan Y, Liu L, Wang D, Wang C, Meng X, Xu J, Wang Y, investigators C (2016) Association between cyp2c19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack. JAMA 316(1):70\u201378. https:\/\/doi.org\/10.1001\/jama.2016.8662","journal-title":"JAMA"},{"issue":"2","key":"9932_CR27","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1468-1331.2012.03861.x","volume":"20","author":"WO Tobin","year":"2013","unstructured":"Tobin WO, Kinsella JA, Coughlan T, Collins DR, O\u2019Neill D, Murphy RP, Egan B, Tierney S, Feeley TM, McCabe DJ (2013) High on-treatment platelet reactivity on commonly prescribed antiplatelet agents following transient ischaemic attack or ischaemic stroke: results from the Trinity Antiplatelet Responsiveness (TRAP) study. Eur J Neurol 20(2):344\u2013352. https:\/\/doi.org\/10.1111\/j.1468-1331.2012.03861.x","journal-title":"Eur J Neurol"},{"issue":"5","key":"9932_CR28","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1365-2141.2010.08539.x","volume":"152","author":"WO Tobin","year":"2011","unstructured":"Tobin WO, Kinsella JA, Collins DR, Coughlan T, O\u2019Neill D, Egan B, Tierney S, Feeley TM, Murphy RP, McCabe DJ (2011) Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) study. Br J Haematol 152(5):640\u2013647. https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08539.x","journal-title":"Br J Haematol"},{"issue":"4","key":"9932_CR29","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1161\/01.STR.0000064326.65899.AC","volume":"34","author":"AJ Grau","year":"2003","unstructured":"Grau AJ, Reiners S, Lichy C, Buggle F, Ruf A (2003) Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study. Stroke 34(4):849\u2013854. https:\/\/doi.org\/10.1161\/01.STR.0000064326.65899.AC","journal-title":"Stroke"},{"issue":"2","key":"9932_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.clinthera.2008.02.006","volume":"30","author":"VL Serebruany","year":"2008","unstructured":"Serebruany VL, Malinin AI, Pokov AN, Hanley DF (2008) Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial. Clin Ther 30(2):249\u2013259. https:\/\/doi.org\/10.1016\/j.clinthera.2008.02.006","journal-title":"Clin Ther"},{"issue":"12","key":"9932_CR31","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1111\/j.1538-7836.2004.01046.x","volume":"2","author":"S Raman","year":"2004","unstructured":"Raman S, Jilma B (2004) Time lag in platelet function inhibition by clopidogrel in stroke patients as measured by PFA-100. J Thromb Haemost 2(12):2278\u20132279. https:\/\/doi.org\/10.1111\/j.1538-7836.2004.01046.x","journal-title":"J Thromb Haemost"},{"issue":"2","key":"9932_CR32","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jacc.2004.09.067","volume":"45","author":"VL Serebruany","year":"2005","unstructured":"Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Bhatt DL, Topol EJ (2005) Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 45(2):246\u2013251. https:\/\/doi.org\/10.1016\/j.jacc.2004.09.067","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"9932_CR33","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1161\/01.STR.0000181081.09262.e1","volume":"36","author":"VL Serebruany","year":"2005","unstructured":"Serebruany VL, Malinin AI, Ziai W, Pokov AN, Bhatt DL, Alberts MJ, Hanley DF (2005) Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in patients after recent ischemic stroke: for the Plavix Use for Treatment of Stroke (PLUTO-Stroke) trial. Stroke 36(10):2289\u20132292. https:\/\/doi.org\/10.1161\/01.STR.0000181081.09262.e1","journal-title":"Stroke"},{"issue":"3","key":"9932_CR34","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ejphar.2004.07.114","volume":"499","author":"VL Serebruany","year":"2004","unstructured":"Serebruany VL, Malinin AI, Sane DC, Jilma B, Takserman A, Atar D, Hennekens CH (2004) Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial. Eur J Pharmacol 499(3):315\u2013324. https:\/\/doi.org\/10.1016\/j.ejphar.2004.07.114","journal-title":"Eur J Pharmacol"},{"key":"9932_CR35","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hrobjartsson A, Kirkham J, Juni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Schunemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919. https:\/\/doi.org\/10.1136\/bmj.i4919","journal-title":"BMJ"},{"issue":"5","key":"9932_CR36","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/09537100400020567","volume":"16","author":"DJ McCabe","year":"2005","unstructured":"McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Lawrie AS, Purdy G, Machin SJ, Brown MM (2005) Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA. Platelets 16(5):269\u2013280. https:\/\/doi.org\/10.1080\/09537100400020567","journal-title":"Platelets"},{"issue":"3","key":"9932_CR37","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1161\/01.STR.24.3.345","volume":"24","author":"CM Helgason","year":"1993","unstructured":"Helgason CM, Tortorice KL, Winkler SR, Penney DW, Schuler JJ, McClelland TJ, Brace LD (1993) Aspirin response and failure in cerebral infarction. Stroke 24(3):345\u2013350","journal-title":"Stroke"},{"issue":"1","key":"9932_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1160\/TH11-06-0436","volume":"107","author":"SH Meves","year":"2012","unstructured":"Meves SH, Overbeck U, Endres HG, Krogias C, Neubauer H (2012) Dose-dependent effect of early antiplatelet therapy in acute ischaemic stroke. Thromb Haemost 107(1):69\u201379. https:\/\/doi.org\/10.1160\/TH11-06-0436","journal-title":"Thromb Haemost"},{"issue":"9","key":"9932_CR39","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/cns.12426","volume":"21","author":"Y Han","year":"2015","unstructured":"Han Y, Lv HH, Liu X, Dong Q, Yang XL, Li SX, Wu S, Jiang JM, Luo Z, Zhu DS, Zhang Y, Zheng Y, Guan YT, Xu JF (2015) Influence of genetic polymorphisms on clopidogrel response and clinical outcomes in patients with acute ischemic stroke CYP2C19 genotype on clopidogrel response. CNS Neurosci Ther 21(9):692\u2013697. https:\/\/doi.org\/10.1111\/cns.12426","journal-title":"CNS Neurosci Ther"},{"issue":"6","key":"9932_CR40","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1161\/STROKEAHA.113.000823","volume":"44","author":"DM Jia","year":"2013","unstructured":"Jia DM, Chen ZB, Zhang MJ, Yang WJ, Jin JL, Xia YQ, Zhang CL, Shao Y, Chen C, Xu Y (2013) CYP2C19 polymorphisms and antiplatelet effects of clopidogrel in acute ischemic stroke in China. Stroke 44(6):1717\u20131719. https:\/\/doi.org\/10.1161\/STROKEAHA.113.000823","journal-title":"Stroke"},{"issue":"10","key":"9932_CR41","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.5551\/jat.33290","volume":"23","author":"X Yi","year":"2016","unstructured":"Yi X, Lin J, Wang Y, Zhou Q, Wang C, Cheng W, Chi L (2016) Association of cytochrome P450 genetic variants with clopidogrel resistance and outcomes in acute ischemic stroke. J Atheroscler Thromb 23(10):1188\u20131200. https:\/\/doi.org\/10.5551\/jat.33290","journal-title":"J Atheroscler Thromb"},{"issue":"9","key":"9932_CR42","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00228-018-2468-7","volume":"74","author":"J Lin","year":"2018","unstructured":"Lin J, Han Z, Wang C, Yi X, Chai Z, Zhou Q, Huang R (2018) Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles. Eur J Clin Pharmacol 74(9):1131\u20131140. https:\/\/doi.org\/10.1007\/s00228-018-2468-7","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"9932_CR43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1161\/01.STR.0000106763.46123.F6","volume":"35","author":"MJ Alberts","year":"2004","unstructured":"Alberts MJ, Bergman DL, Molner E, Jovanovic BD, Ushiwata I, Teruya J (2004) Antiplatelet effect of aspirin in patients with cerebrovascular disease. Stroke 35(1):175\u2013178. https:\/\/doi.org\/10.1161\/01.STR.0000106763.46123.F6","journal-title":"Stroke"},{"issue":"6","key":"9932_CR44","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1097\/MBC.0000000000000118","volume":"25","author":"E Jover","year":"2014","unstructured":"Jover E, Rodriguez JM, Bernal A, Arroyo AB, Iniesta JA, Guiu IS, Martinez C, Vicente V, Lozano ML, Rivera J (2014) High on-treatment platelet reactivity in patients with ischemic cerebrovascular disease: assessment of prevalence and stability over time using four platelet function tests. Blood Coagul Fibrinolysis 25(6):604\u2013611. https:\/\/doi.org\/10.1097\/MBC.0000000000000118","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"7329","key":"9932_CR45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","unstructured":"Antithrombotic Trialists\u2019 Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324(7329):71\u201386","journal-title":"BMJ"},{"key":"9932_CR46","doi-asserted-by":"publisher","first-page":"l2211","DOI":"10.1136\/bmj.l2211","volume":"365","author":"Y Wang","year":"2019","unstructured":"Wang Y, Chen W, Lin Y, Meng X, Chen G, Wang Z, Wu J, Wang D, Li J, Cao Y, Xu Y, Zhang G, Li X, Pan Y, Li H, Zhao X, Liu L, Lin J, Dong K, Jing J, Johnston SC, Wang D, Wang Y, Group PPS (2019) Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial. BMJ 365:l2211. https:\/\/doi.org\/10.1136\/bmj.l2211","journal-title":"BMJ"},{"issue":"4","key":"9932_CR47","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1159\/000118382","volume":"25","author":"Y Schwammenthal","year":"2008","unstructured":"Schwammenthal Y, Tsabari R, Shenkman B, Schwartz R, Matetzky S, Lubetsky A, Orion D, Israeli-Korn S, Chapman J, Savion N, Varon D, Tanne D (2008) Aspirin responsiveness in acute brain ischaemia: association with stroke severity and clinical outcome. Cerebrovasc Dis 25(4):355\u2013361. https:\/\/doi.org\/10.1159\/000118382","journal-title":"Cerebrovasc Dis"},{"issue":"6","key":"9932_CR48","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/jcbfm.2008.9","volume":"28","author":"NA Englyst","year":"2008","unstructured":"Englyst NA, Horsfield G, Kwan J, Byrne CD (2008) Aspirin resistance is more common in lacunar strokes than embolic strokes and is related to stroke severity. J Cereb Blood Flow Metab 28(6):1196\u20131203. https:\/\/doi.org\/10.1038\/jcbfm.2008.9","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"9932_CR49","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.clineuro.2010.11.004","volume":"113","author":"JM Bugnicourt","year":"2011","unstructured":"Bugnicourt JM, Roussel B, Garcia PY, Canaple S, Lamy C, Godefroy O (2011) Aspirin non-responder status and early neurological deterioration: a prospective study. Clin Neurol Neurosurg 113(3):196\u2013201. https:\/\/doi.org\/10.1016\/j.clineuro.2010.11.004","journal-title":"Clin Neurol Neurosurg"},{"issue":"10","key":"9932_CR50","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jcma.2012.07.005","volume":"75","author":"PT Lai","year":"2012","unstructured":"Lai PT, Chen SY, Lee YS, Ho YP, Chiang YY, Hsu HY (2012) Relationship between acute stroke outcome, aspirin resistance, and humoral factors. J Chin Med Assoc 75(10):513\u2013518. https:\/\/doi.org\/10.1016\/j.jcma.2012.07.005","journal-title":"J Chin Med Assoc"},{"issue":"3\u20134","key":"9932_CR51","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000438722","volume":"74","author":"C Coignion","year":"2015","unstructured":"Coignion C, Poli M, Sagnier S, Freyburger G, Renou P, Debruxelles S, Rouanet F, Sibon I (2015) Interest of antiplatelet drug testing after an acute ischemic stroke. Eur Neurol 74(3\u20134):135\u2013139. https:\/\/doi.org\/10.1159\/000438722","journal-title":"Eur Neurol"},{"issue":"2","key":"9932_CR52","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1001\/jamaneurol.2013.601","volume":"70","author":"AS Zheng","year":"2013","unstructured":"Zheng AS, Churilov L, Colley RE, Goh C, Davis SM, Yan B (2013) Association of aspirin resistance with increased stroke severity and infarct size. JAMA Neurol 70(2):208\u2013213. https:\/\/doi.org\/10.1001\/jamaneurol.2013.601","journal-title":"JAMA Neurol"},{"issue":"4","key":"9932_CR53","doi-asserted-by":"publisher","first-page":"e0120743","DOI":"10.1371\/journal.pone.0120743","volume":"10","author":"JT Kim","year":"2015","unstructured":"Kim JT, Heo SH, Lee JS, Choi MJ, Choi KH, Nam TS, Lee SH, Park MS, Kim BC, Kim MK, Cho KH (2015) Aspirin resistance in the acute stages of acute ischemic stroke is associated with the development of new ischemic lesions. PLoS One 10(4):e0120743. https:\/\/doi.org\/10.1371\/journal.pone.0120743","journal-title":"PLoS One"},{"issue":"3","key":"9932_CR54","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1161\/CIRCULATIONAHA.112.117283","volume":"127","author":"T Grosser","year":"2013","unstructured":"Grosser T, Fries S, Lawson JA, Kapoor SC, Grant GR, FitzGerald GA (2013) Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin. Circulation 127(3):377\u2013385. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.117283","journal-title":"Circulation"},{"issue":"6","key":"9932_CR55","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jacc.2016.11.050","volume":"69","author":"DL Bhatt","year":"2017","unstructured":"Bhatt DL, Grosser T, Dong JF, Logan D, Jeske W, Angiolillo DJ, Frelinger AL 3rd, Lei L, Liang J, Moore JE, Cryer B, Marathi U (2017) Enteric coating and aspirin nonresponsiveness in patients with type 2 diabetes mellitus. J Am Coll Cardiol 69(6):603\u2013612. https:\/\/doi.org\/10.1016\/j.jacc.2016.11.050","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09932-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-09932-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09932-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T19:31:45Z","timestamp":1623180705000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-09932-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,9]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["9932"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-09932-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,9]]},"assertion":[{"value":"28 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, we state that there are no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"These data were collated as part of a systematic review and meta-analysis, our Local Research Ethics Committee (LREC) hospital guidelines indicate that formal LREC approval for such a study is not required. However, all data were securely stored in electronic format and no individual patient could be identified from the data contained within. The study and analyses were conducted in accordance with best ethical practice and supervised by experienced Consultants who are International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Good Clinical Practice (ICH GCP)-certified.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}